117 related articles for article (PubMed ID: 2096920)
1. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
[TBL] [Abstract][Full Text] [Related]
2. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
4. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
Garg S; Garg PK; Zalutsky MR
Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411
[TBL] [Abstract][Full Text] [Related]
5. Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics.
Chen J; Wang M; Joyce A; DeFranco D; Kavosi M; Xu X; O'Hara DM
Pharm Res; 2014 Oct; 31(10):2810-21. PubMed ID: 24844406
[TBL] [Abstract][Full Text] [Related]
6. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
[TBL] [Abstract][Full Text] [Related]
7. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
8. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
[TBL] [Abstract][Full Text] [Related]
10. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
[TBL] [Abstract][Full Text] [Related]
11. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
12. Observations on the Effects of Residualization and Dehalogenation on the Utility of
Chitneni SK; Koumarianou E; Vaidyanathan G; Zalutsky MR
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671554
[TBL] [Abstract][Full Text] [Related]
13. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
14. A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).
Vaidyanathan G; Affleck DJ; Li J; Welsh P; Zalutsky MR
Bioconjug Chem; 2001; 12(3):428-38. PubMed ID: 11353542
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity.
Garg PK; Garg S; Zalutsky MR
Bioconjug Chem; 1991; 2(1):44-9. PubMed ID: 1878410
[TBL] [Abstract][Full Text] [Related]
16. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
Vaidyanathan G; Zalutsky MR
Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods.
Nestor M; Persson M; Cheng J; Tolmachev V; van Dongen G; Anniko M; Kairemo K
Bioconjug Chem; 2003; 14(4):805-10. PubMed ID: 12862434
[TBL] [Abstract][Full Text] [Related]
18. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
[TBL] [Abstract][Full Text] [Related]
19. Radioiodination and biodistribution of quantum dots using Bolton-Hunter reagent.
Park JJ; Lee TS; Kang JH; Song R; Cheon GJ
Appl Radiat Isot; 2011 Jan; 69(1):56-62. PubMed ID: 20888778
[TBL] [Abstract][Full Text] [Related]
20. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Garg S; Garg PK; Zhao XG; Friedman HS; Bigner DD; Zalutsky MR
Nucl Med Biol; 1993 Oct; 20(7):835-42. PubMed ID: 8241995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
